Effects of retinoic acid and fenretinide on the c-erbB 2 expression, growth and cisplatin sensitivity of breast cancer cells
1998

Effects of Retinoic Acid and Fenretinide on Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): ThW Grunt, E Dittrich, M Offterdinger, SM Schneider, Ch Dittrich, H Huber

Primary Institution: University of Vienna

Hypothesis

How do retinoic acid and fenretinide affect c-erbB-2 expression and sensitivity to cisplatin in breast cancer cells?

Conclusion

Both retinoids down-regulate c-erbB-2 expression and enhance the sensitivity of breast cancer cells to cisplatin.

Supporting Evidence

  • Retinoids down-regulate c-erbB-2 protein and mRNA in breast cancer cells.
  • ATRA induces differentiation in SK-BR-3 cells.
  • 4-HPR causes apoptosis in breast cancer cells.
  • Combinations of retinoids with cisplatin enhance growth inhibition.
  • Retinoid conditioning is essential for improved antiproliferative effects.

Takeaway

This study shows that two drugs, retinoic acid and fenretinide, can help make breast cancer cells more sensitive to a chemotherapy drug called cisplatin.

Methodology

The study used ELISA, Western blotting, and Northern blotting to analyze the effects of retinoids on breast cancer cell lines.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication